Authors:
Sahota, O
Fowler, I
Blackwell, PJ
Lawson, N
Cawte, SA
San, P
Masud, T
Hosking, DJ
Citation: O. Sahota et al., A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: A randomized controlled trial, OSTEOPOR IN, 11(11), 2000, pp. 959-966
Authors:
Sahota, O
Pearson, D
Cawte, SW
San, P
Hosking, DJ
Citation: O. Sahota et al., Site-specific variation in the classification of osteoporosis, and the diagnostic reclassification using the lowest individual lumbar vertebra T-score compared with the L1-L4 mean, in early postmenopausal women, OSTEOPOR IN, 11(10), 2000, pp. 852-857
Authors:
Sahota, O
San, P
Cawte, SA
Pearson, D
Hosking, DJ
Citation: O. Sahota et al., A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: The four-year effects of hormone replacement therapy, OSTEOPOR IN, 11(1), 2000, pp. 52-58
Citation: O. Sahota, Osteoporosis and the role of vitamin D and calcium-vitamin D deficiency, vitamin D insufficiency and vitamin D sufficiency, AGE AGEING, 29(4), 2000, pp. 301-304
Citation: O. Sahota et al., Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis, CLIN ENDOCR, 51(2), 1999, pp. 217-221
Authors:
Ravn, P
Bidstrup, M
Wasnich, RD
Davis, JW
McClung, MR
Balske, A
Coupland, C
Sahota, O
Kaur, A
Daley, M
Cizza, G
Citation: P. Ravn et al., Alendronate and estrogen-progestin in the long-term prevention of bone loss: Four-year results from the early postmenopausal intervention cohort study - A randomized, controlled trial, ANN INT MED, 131(12), 1999, pp. 935